1-20 of 25
Alex F. Herrera
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti–PD-1–refractory Hodgkin lymphoma

Open Access
Clinical Trials & Observations
Philippe Armand, Pier Luigi Zinzani, John Timmerman, Nathalie A. Johnson, David Lavie, Kannan Thiagarajan, Brian G. Topp, Pallavi Pillai, Alex F. Herrera
Journal: Blood Advances
Blood Adv (2025) 9 (19): 4987–4995.
https://doi.org/10.1182/bloodadvances.2024014654
Published: 2025
Includes: Supplemental data
Journal Articles

Multifaceted cfDNA profiling in mantle cell lymphoma

Open Access
Clinical Trials & Observations
Brian J. Sworder, Alex F. Herrera
Journal: Blood Advances
Blood Adv (2025) 9 (17): 4526–4527.
https://doi.org/10.1182/bloodadvances.2025017086
Published: 2025
Journal Articles

Camidanlumab Tesirine for Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study

Open Access
Clinical Trials & Observations
Alex F. Herrera, Stephen M. Ansell, Pier Luigi Zinzani, John Radford, Kami J Maddocks, Antonio Pinto, Graham P. Collins, Veronika Bachanova, Nancy L. Bartlett, Isabelle Bence-Bruckler, Mehdi Hamadani, Justin Kline, Jiri Mayer, Kerry J. Savage, Ranjana H Advani, Paolo F. Caimi, Olivier Casasnovas, Tatyana A. Feldman, Brian T Hess, Mariana Bastos-Oreiro, Sunil Iyengar, Árpád Szomor, William Townsend, Marc André, Jerzy Dyczkowski, Karin Havenith, Marie Toukam, Serafino Pantano, Hans G. Cruz, Luqiang Wang, Yanina Negievich, Melanie Lucero, Jens U. Wuerthner, Carmelo Carlo-Stella
Journal: Blood Advances
Blood Adv bloodadvances.2024015600.
https://doi.org/10.1182/bloodadvances.2024015600
Published: 2025
Includes: Supplemental data
Journal Articles

Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis

Open Access
Nausheen Ahmed, Swetha Thiruvengadam, Mehdi Hamadani, Zhen-Huan Hu, Natalie S. Grover, Mazyar Shadman, Frederick L. Locke, James Gerson, Matthew J Frank, Lihua E Budde, Michael L Wang, Soyoung Kim, Matthew Bye, Mohamed A Kharfan-Dabaja, Craig S. Sauter, Peiman Hematti, Cameron J. Turtle, Sairah Ahmed, Amy Moskop, Brent R. Logan, Ana Nunes, David M. Dalton, Ioana Magdalena Kloos, Dr, Daniel Lee, Hairong Xu, Marcelo C. Pasquini, Alex F. Herrera
Journal: Blood Advances
Blood Adv bloodadvances.2024015014.
https://doi.org/10.1182/bloodadvances.2024015014
Published: 2025
Includes: Supplemental data
Journal Articles

New strategies for enhancing enrollment of underrepresented minorities in lymphoma clinical trials

Open Access
Chijioke Nze, Alex F. Herrera
Journal: Blood Advances
Blood Adv (2025) 9 (4): 774–782.
https://doi.org/10.1182/bloodadvances.2024012981
Published: 2025
Journal Articles

Evaluation of prognostic factors in patients with high-risk classical Hodgkin lymphoma undergoing autologous transplantation

Free
Narendranath Epperla, Ying Huang, Amanda F. Cashen, John L. Vaughn, Walter Hanel, Talha Badar, Stefan K. Barta, Paolo F. Caimi, Tarsheen K. Sethi, Nishitha Reddy, Reem Karmali, Celeste Bello, Julio C. Chavez, Shalin K. Kothari, Francisco J. Hernandez-Ilizaliturri, Jakub Svoboda, Frederick Lansigan, Martha J. Glenn, Jonathon B. Cohen, Caryn Sorge, Beth Christian, Alex F. Herrera, Mehdi Hamadani, Luciano J. Costa, Ana C. Xavier
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5458–5466.
https://doi.org/10.1182/bloodadvances.2024013743
Published: 2024
Includes: Supplemental data
Journal Articles

Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma

Free
Clinical Trials & Observations
Jasmine Zain, Ni-Chun Tsai, Joycelynne Palmer, Jennifer Simpson, Vikram Adhikarla, James R. Bading, Paul Yazaki, Eileen P. Smith, Savita Dandapani, Joo Y. Song, Nicole A. Karras, Alex F. Herrera, Amandeep Salhotra, Auayporn P. Nademanee, Ryotaro Nakamura, D. Lynne Smith, David Yamauchi, Erasmus K. Poku, V. Eric Biglang-Awa, David Colcher, John E. Shively, Anna M. Wu, Stephen J. Forman, Jeffrey Wong, Sandra Thomas
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4812–4822.
https://doi.org/10.1182/bloodadvances.2023012497
Published: 2024
Includes: Supplemental data
Journal Articles

Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score–matched analysis

Free
Clinical Trials & Observations
Julia Driessen, Fer de Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. LaCasce, Peter D. Cole, Craig H. Moskowitz, Ramón García-Sanz, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée M. Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2740–2752.
https://doi.org/10.1182/bloodadvances.2023012145
Published: 2024
Includes: Supplemental data
Journal Articles

Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation

Free
Reid W. Merryman, Robert A. Redd, Eleanor Taranto, Gulrayz Ahmed, Erin Jeter, Kristin M. McHugh, Jennifer R. Brown, Jennifer L. Crombie, Matthew S. Davids, David C. Fisher, Arnold S. Freedman, Eric Jacobsen, Caron A. Jacobson, Austin I. Kim, Ann S. LaCasce, Samuel Y. Ng, Oreofe O. Odejide, Erin M. Parry, Heather Jacene, Hyesun Park, Parastoo B. Dahi, Yago Nieto, Robin M. Joyce, Yi-Bin Chen, Margaret A. Shipp, Alex F. Herrera, Philippe Armand
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4748–4759.
https://doi.org/10.1182/bloodadvances.2022007706
Published: 2023
Includes: Supplemental data
Journal Articles

Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma

Free
Clinical Trials & Observations
Tycel J. Phillips, David Bond, Radihka Takiar, Karson Kump, Malalthi Kandarpa, Philip Boonstra, Tera Lynn Mayer, Victoria Nachar, Ryan A. Wilcox, Shannon A. Carty, Yasmin H. Karimi, Zaneta Nikolovska-Coleska, Mark S. Kaminski, Alex F. Herrera, Kami Maddocks, Leslie Popplewell, Alexey V. Danilov
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4518–4527.
https://doi.org/10.1182/bloodadvances.2023009992
Published: 2023
Includes: Supplemental data
Journal Articles

Postibrutinib relapse outcomes for patients with marginal zone lymphoma

Free
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K. Moyo, Nishitha Reddy, Julia Sheets, David M. Weiner, Praveen Ramakrishnan Geethakumari, Malathi Kandarpa, Ximena Jordan Bruno, Colin Thomas, Michael C. Churnetski, Andrew Hsu, Luke Zurbriggen, Xiao-wei Cherie Tan, Kathryn Lindsey, Joseph Maakaron, Paolo F. Caimi, Pallawi Torka, Celeste Bello, Sabarish Ayyappan, Timothy S. Oh, Reem Karmali, Seo-Hyun Kim, Anna Kress, Shalin Kothari, Yazeed Sawalha, Beth Christian, Kevin A. David, Irl Brian Greenwell, Murali Janakiram, Vaishalee P. Kenkre, Adam J. Olszewski, Jonathon B. Cohen, Neil Palmisiano, Elvira Umyarova, Ryan A. Wilcox, Farrukh T. Awan, Juan Pablo Alderuccio, Stefan K. Barta, Natalie S. Grover, Nilanjan Ghosh, Nancy L. Bartlett, Alex F. Herrera, Geoffrey Shouse
Journal: Blood Advances
Blood Adv (2023) 7 (1): 88–91.
https://doi.org/10.1182/bloodadvances.2022008634
Published: 2023
Includes: Supplemental data
Journal Articles

Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines

Free
Jibin Zhang, Tingting Wang, Kunal Shetty, Serhan Alkan, Senlin Xu, Qiang Gong, Xuxiang Liu, Yuping Li, Zunsong Hu, Wendong Huang, Hans-Guido Wendel, Alex F. Herrera, Raju K. Pillai, Joo Y. Song, Wing C. Chan
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5067–5071.
https://doi.org/10.1182/bloodadvances.2021006709
Published: 2022
Includes: Supplemental data
Journal Articles

An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma

Free
Clinical Trials & Observations
Juan Pablo Alderuccio, Luca Arcaini, Marcus P. Watkins, Anne W. Beaven, Geoffrey Shouse, Narendranath Epperla, Michele Spina, Alexandra Stefanovic, Jose Sandoval-Sus, Pallawi Torka, Ash B. Alpert, Adam J. Olszewski, Seo-Hyun Kim, Brian Hess, Sameh Gaballa, Sabarish Ayyappan, Jorge J. Castillo, Lisa Argnani, Timothy J. Voorhees, Raya Saba, Sayan Mullick Chowdhury, Fernando Vargas, Isildinha M. Reis, Deukwoo Kwon, Jonathan S. Alexander, Wei Zhao, Dali Edwards, Peter Martin, Emanuele Cencini, Manali Kamdar, Brian K. Link, Constantine N. Logothetis, Alex F. Herrera, Jonathan W. Friedberg, Brad S. Kahl, Stefano Luminari, Pier Luigi Zinzani, Izidore S. Lossos
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2035–2044.
https://doi.org/10.1182/bloodadvances.2021006844
Published: 2022
Journal Articles

Risk profiling of patients with relapsed/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA

Free
Clinical Trials & Observations
Alex F. Herrera, Samuel Tracy, Brandon Croft, Stephen Opat, Jill Ray, Alex F. Lovejoy, Lisa Musick, Joseph N. Paulson, Laurie H. Sehn, Yanwen Jiang
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1651–1660.
https://doi.org/10.1182/bloodadvances.2021006415
Published: 2022
Includes: Supplemental data
Journal Articles

Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics

Free
Clinical Trials & Observations
Mehdi Hamadani, Maud Ngoya, Anna Sureda, Qaiser Bashir, Carlos Alejandro Litovich, Hervé Finel, Yue Chen, Ariane Boumendil, Jasmine Zain, Luca Castagna, Amanda F. Cashen, Didier Blaise, Mazyar Shadman, Rocco Pastano, Farhad Khimani, Mutlu Arat, Sascha Dietrich, Norbert Schmitz, Bertram Glass, Mohamed A. Kharfan-Dabaja, Paolo Corradini, Craig S. Sauter, Silvia Montoto, Mi Kwon, Alex F. Herrera, Peter Dreger
Journal: Blood Advances
Blood Adv (2022) 6 (3): 920–930.
https://doi.org/10.1182/bloodadvances.2021005899
Published: 2022
Includes: Supplemental data
Journal Articles

Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data

Free
Clinical Trials & Observations
Laurie H. Sehn, Mark Hertzberg, Stephen Opat, Alex F. Herrera, Sarit Assouline, Christopher R. Flowers, Tae Min Kim, Andrew McMillan, Muhit Ozcan, Violaine Safar, Gilles Salles, Grace Ku, Jamie Hirata, Yi Meng Chang, Lisa Musick, Matthew J. Matasar
Journal: Blood Advances
Blood Adv (2022) 6 (2): 533–543.
https://doi.org/10.1182/bloodadvances.2021005794
Published: 2022
Includes: Supplemental data
Journal Articles

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma

Free
Clinical Trials & Observations
Alex F. Herrera, Joycelynne Palmer, Vikram Adhikarla, Dave Yamauchi, Erasmus K. Poku, James Bading, Paul Yazaki, Savita Dandapani, Matthew Mei, Robert Chen, Thai Cao, Nicole Karras, Pamela McTague, Auayporn Nademanee, Leslie Popplewell, Firoozeh Sahebi, John E. Shively, Jennifer Simpson, D. Lynne Smith, Joo Song, Ricardo Spielberger, Ni-Chun Tsai, Sandra H. Thomas, Stephen J. Forman, David Colcher, Anna M. Wu, Jeffrey Wong, Eileen Smith
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5300–5311.
https://doi.org/10.1182/bloodadvances.2021004981
Published: 2021
Includes: Supplemental data
Journal Articles

Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma

Free
Clinical Trials & Observations
Michael Dickinson, Javier Briones, Alex F. Herrera, Eva González-Barca, Nilanjan Ghosh, Raul Cordoba, Sarah C. Rutherford, Eirini Bournazou, Emily Labriola-Tompkins, Izolda Franjkovic, Evelyne Chesne, Jurriaan Brouwer-Visser, Katharina Lechner, Barbara Brennan, Eveline Nüesch, Mark DeMario, Dominik Rüttinger, Martin Kornacker, Martin Hutchings
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4762–4770.
https://doi.org/10.1182/bloodadvances.2021004619
Published: 2021
Includes: Supplemental data
Journal Articles

Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma

Free
Clinical Trials & Observations
Jennifer L. Crombie, Loretta J. Nastoupil, Robert Redd, Kevin Tang, Geoffrey Shouse, Alex F. Herrera, Victor A. Chow, Mazyar Shadman, Omar Castaneda Puglianini, Anna Saucier, Caron A. Jacobson, Philippe Armand, Gary Simmons
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3563–3567.
https://doi.org/10.1182/bloodadvances.2021004880
Published: 2021
Journal Articles

Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome

Free
Clinical Trials & Observations
Alex F. Herrera, Kwang Woo Ahn, Carlos Litovich, Yue Chen, Amer Assal, Qaiser Bashir, Ruthee-Lu Bayer, Melanie Coleman, Zachariah DeFilipp, Nosha Farhadfar, Matthew Greenwood, Theresa Hahn, Mitchell Horwitz, Caron Jacobson, Samantha Jaglowski, Sylvie Lachance, Amelia Langston, Bassam Mattar, Richard T. Maziarz, Joseph McGuirk, Mohammad A. H. Mian, Sunita Nathan, Adrienne Phillips, Kevin Rakszawski, Henrik Sengeloev, Shalini Shenoy, Robert Stuart, Craig S. Sauter, Mohamed A. Kharfan-Dabaja, Mehdi Hamadani
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3528–3539.
https://doi.org/10.1182/bloodadvances.2021004865
Published: 2021
Includes: Supplemental data